Stock Events

Malin 

€5.6
4
-€0.3-5.08% Wednesday 15:30

Statistics

Day High
5.9
Day Low
5.7
52W High
6.1
52W Low
3.84
Volume
15,587
Avg. Volume
13,750
Mkt Cap
211.43M
P/E Ratio
12.5
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14FebExpected
Q2 2023
Q4 2023
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MLC.IR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novavax
NVAX
Mkt Cap555.61M
Novavax competes in the biotechnology sector focusing on developing vaccines, which aligns with Malin's investment in life sciences and healthcare.
Moderna
MRNA
Mkt Cap38.83B
Moderna is a leader in mRNA technology for vaccines and therapeutics, directly competing with Malin's interests in innovative healthcare solutions.
Biomarin Pharmaceutical
BMRN
Mkt Cap16.73B
BioMarin Pharmaceutical focuses on rare disease treatments, overlapping with Malin's investment strategy in unique healthcare solutions.
Vertex Pharmaceuticals
VRTX
Mkt Cap101.91B
Vertex Pharmaceuticals is involved in creating treatments for serious diseases, competing with Malin's focus on high-impact healthcare investments.
Regeneron Pharmaceuticals
REGN
Mkt Cap96.81B
Regeneron Pharmaceuticals is known for its innovative biotech treatments, competing in the same space as Malin's healthcare and life sciences investments.
Alnylam Pharmaceuticals
ALNY
Mkt Cap18.19B
Alnylam Pharmaceuticals specializes in RNAi therapeutics, competing with Malin's focus on groundbreaking healthcare technologies.
Incyte
INCY
Mkt Cap11.75B
Incyte Corporation works on small molecule drugs for oncology and inflammation, competing with Malin's healthcare investment interests.
Gilead Sciences
GILD
Mkt Cap83.12B
Gilead Sciences is a biopharmaceutical company with a focus on antiviral drugs, competing with Malin's interest in innovative healthcare solutions.
AMGEN
AMGN
Mkt Cap144.25B
Amgen is a biotech firm focusing on human therapeutics, competing in the broad biotech and healthcare sector where Malin is also active.

About

Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an unmet need in women's health and onychomycosis or fungal nail infection. The company also provides drugs for protein misfolding diseases; and platform to distinguish disease-driving bacteria from the intestinal microbiota, as well as UV-light disinfection technology solutions. In addition, it provides company secretarial services. Malin Corporation plc was incorporated in 2014 and is headquartered in Dublin, Ireland.
Show more...
CEO
Mr. Darragh Fergal Lyons
Employees
6
Country
IE
ISIN
IE00BVGC3741

Listings